Advancing clinical staging in invasive breast carcinoma: the role of contrast-enhanced mammography
Open Access
- 7 May 2025
- journal article
- Published by Termedia Sp. z.o.o. in Polish Journal of Radiology
- Vol. 90, 207-214
Abstract
Purpose: This study compares breast carcinoma (BC) clinical tumour staging by contrast-enhanced mammography (CEM), full-field digital mammography (FFDM), and ultrasound (US). Clinical staging is essential for multidisciplinary teams to develop optimal treatment plans and for cancer registries to generate accurate analyses of cancer epidemiology.Material and methods: Data on tumour size and the presence of multiplicity were extracted from radiology reports. Primary tumour staging (cT category) was established for each imaging modality. Enrolled cases (n = 78, adult females) had FFDM and US performed up to a month prior to CEM. Fisher’s exact test was used to examine the relationship between cT stage determination and diagnostic methods.Results: Tumour size was largest in CEM (median 47 mm), followed by FFDM (median 33 mm), and smallest in US (median 23 mm). There were statistically significant differences in the distribution of cT categories between the 3 imaging modalities, with cT2 and cT1 being most common in US (46% and 41%, respectively) and FFDM (53% and 19%, respectively). Staging by CEM followed a different pattern, with cT2 and cT3 being most common (both 38%). The multiplicity rate was equal for CEM and US (42%), with fewer cases in FFDM (13%).Conclusions: The tumour size measured by CEM is greater compared to measurements obtained through US and FFDM. Given the strong correlation between CEM and histopathology reported in the literature, CEM enhances the accuracy of local tumour staging in BC, thereby minimising the risk of understaging.Keywords
This publication has 39 references indexed in Scilit:
- Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesionsLa radiologia medica, 2019
- Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer DatabaseBreast Cancer Research and Treatment, 2018
- Skin Tumours2017
- Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breastsBreast Cancer, 2016
- Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm): A review of 5685 medicare patientsCancer, 2015
- Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteriaEuropean Radiology, 2015
- Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysisEuropean Radiology, 2014
- Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programmeEuropean Radiology, 2014
- Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour sizeEuropean Radiology, 2013
- Dual-energy contrast-enhanced digital mammography: initial clinical resultsEuropean Radiology, 2010